Skip to content
Cultural Foundation
Author:
LB Pharmaceuticals Inc
LB Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 12, 2026
LB Pharmaceuticals Announces Publication in JAMA Psychiatry of Results from Phase 2 NOVA-1 Trial of LB-102 in Schizophrenia
April 22, 2026
←
Previous Page
1
2